M. Graham

发表

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

C. Perou, L. Carey, D. Moore, 2007, Clinical Cancer Research.

Evidence of estrogen receptors in normal human osteoblast-like cells.

K. Mann, B. Riggs, T. Spelsberg, 1988, Science.

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

D. Berry, E. Winer, C. Hudis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.

James P Evans, L. Lange, J. Booker, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

D. Amadori, M. Moroni, N. Ibrahim, 2021, Breast Cancer Research and Treatment.

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

Thomas J. Smith, P. Novotny, R. Leon-Ferre, 2019, JNCI cancer spectrum.

Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.

J. Ibrahim, L. Carey, James P Evans, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.

N. Robert, C. Isaacs, B. Overmoyer, 1997, Journal of Clinical Oncology.

Pulmonary lymphangiomyomatosis: with particular reference to steroid-receptor assay studies and pathologic correlation.

W. Payne, T. Spelsberg, M. Graham, 1984, Mayo Clinic proceedings.

Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue.

C. Civin, P. Colombani, M. Wharam, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Alu‐mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10

B. Weber, J. Garber, G. Lenoir, 2000, Genes, chromosomes & cancer.

Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays.

B. Scheithauer, E. Laws, M. Press, 1989, Neurosurgery.

Cancers to Hormone Resistance Receptor Mutations , Are a Model for the Progression of Breast Cells , Genetically Unstable and Containing EstrogenCOT 47 D Updated

K. Horwitz, K. Leslie, N. Krett, 2006 .

Dco Cells , Genetically Unstable and Containing Estrogen Receptor Mutations , Are a Model for the Progression of Breast Cancers to Hormone Resistance 1

K. Horwitz, K. Leslie, N. Krett, 2006 .

Evidence for an androgen receptor in human testis.

T. Spelsberg, M. Graham, C. Coulam, 1984, American journal of obstetrics and gynecology.

A randomized trial of five years of letrozole versus placebo after aromatase inhibitor-based therapy: NRG Oncology/NSABP B-42

S. Paik, C. Geyer, S. Swain, 2019 .

T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.

K. Horwitz, K. Leslie, N. Krett, 1990, Cancer research.

Androgen insensitivity syndrome: gonadal androgen receptor activity.

T. Spelsberg, M. Graham, C. Coulam, 1984, American journal of obstetrics and gynecology.

Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays.

B. Scheithauer, E. Laws, M. Press, 1989, Neurosurgery.

Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line.

K. Horwitz, M. Graham, K. Dalquist, 1989, Cancer research.

Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines.

K. Horwitz, P. Bunn, P. Jewett, 1989, Cancer research.

Identification of putative nonfunctional steroid receptors in breast and endometrial cancer.

D. Schaid, J. Ingle, K. Podratz, 1990, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A nuclear binding assay for measurement of biologically active androgen receptors in animal tissues and human prostate cancer.

T. Spelsberg, M. Lieber, M. Graham, 1988, Journal of steroid biochemistry.

Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.

G. Hortobagyi, L. Sutton, M. Somerville, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of Low-Dose Infusional 5-Fluorouracil and Paclitaxel (Taxol) Given Every 2 Weeks in Metastatic Breast Cancer

J. Griggs, F. Collichio, M. Graham, 2002, American journal of clinical oncology.

Evidence of estrogen receptors in normal human osteoblast-like cells

Kenneth G. Mann, Thomas C. Spelsberg, Mark L. Graham, 1988 .

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group

G. T. Budd, R. Gray, S. Martino, 2011, Medical Oncology.

Dual Parameter Flow Cytometry Cultured Human Breast Cancer Cells : Analysis by Quantitative Remodeling by Tamoxifen Characterize Subpopulations of Heterogeneity of Progesterone Receptor Content and Updated

K. Horwitz, P. Jewett, M. Graham, 2006 .

Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry.

K. Horwitz, P. Jewett, M. Graham, 1992, Cancer research.

T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.

K. Horwitz, K. Leslie, N. Krett, 1990, Cancer research.

Phase II trial of tanespimycin (KOS-953), a heat shock protein-90 (Hsp90) inhibitor in patients with metastatic melanoma

P. Hersey, M. Millward, R. Kefford, 2007 .

American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome.

L. Carey, E. Dees, L. Sawyer, 2005, Journal of the National Cancer Institute.

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

L. Carey, J. Frelinger, J. Serody, 2004, Cancer Immunology, Immunotherapy.

Central nervous system metastases in women after multimodality therapy for high risk breast cancer

L. Carey, E. Dees, M. Ewend, 2004, Breast Cancer Research and Treatment.

Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105.

A. Neugut, S. Ramsey, J. Unger, 2019, Journal of Clinical Oncology.

Disproportionate CNS relapse after aggressive neoadjuvant chemotherapy

L. Carey, E. Dees, M. Ewend, 2001 .

Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.

A. Neugut, S. Ramsey, J. Unger, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.

S. Paik, C. Geyer, D. Wickerham, 2019, The Lancet. Oncology.

Organochlorines and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) in Cancerous and Noncancerous Breast Tissue: Do the Data Support the Hypothesis That Oxidative DNA Damage Caused by Organochlorines Affects Breast Cancer?

M. Schell, M. Graham, E. Willman, 2001, Archives of environmental contamination and toxicology.

Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue.

J. Ingle, T. Spelsberg, M. Graham, 1988, Clinical chemistry.

A nuclear binding assay to assess the biological activity of steroid receptors in isolated animal and human tissues.

J. Ingle, T. Spelsberg, M. Graham, 1987, Endocrinology.

Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity.

J. Ibrahim, L. Carey, H. McLeod, 2016, The oncologist.

Breast Cancer Tamoxifen Dose Escalation in Patients With Diminished CYP 2 D 6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity

J. Ibrahim, L. Carey, H. McLeod, 2016 .

Breast cancer survival and the timing of tumor removal during the menstrual cycle.

L. Melton, D. Baird, J. Donohue, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Response and cardiac toxicity of trastuzumab given in conjunction with weekly paclitaxel after doxorubicin/cyclophosphamide.

L. Carey, L. Dressler, A. Ivanova, 2006, Clinical breast cancer.

Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases

R. Semelka, T. Noone, M. Graham, 1999, Journal of magnetic resonance imaging : JMRI.